Delivery Order SPE2DB22D3016-SPE2DB24FAZP2
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,302.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, to support military healthcare programs. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. This award is part of AmerisourceBergen's...
This federal contract award, valued at $9,116.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion 30s, a pharmaceutical product used in medical treatment. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of cyclosporine 0.05% eye emulsion. The contract, valued at $8,917.01, is a Firm Fixed Price Delivery Order with a completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,064.14 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award, valued at $1,838.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Cyclosporine 0.05% Eye Emulsion, a medication used to treat certain eye conditions. The contract has an ultimate completion date of January 2, 2024 and is a firm-fixed-price contract. In addition to this specific delivery order, AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,783.43, is for the delivery of cyclosporine 0.05% eye emulsion in 60-count packages. The contract has a performance period through March 4, 2024 and uses a firm fixed-price pricing type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $9,636.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Cyclosporine 0.05% Eye Emulsion, a medication used to treat certain eye conditions. The contract has a firm fixed price and an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,527.92 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has a completion date of November 1, 2024 and was awarded on October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $8,756.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,312,299 units of cyclosporine 0.05% eye emulsion, a specialty medication. This is a firm-fixed-price delivery order with a completion date of June 22, 2023. The contract was not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,152.79 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...